Original language | English |
---|---|
Pages (from-to) | e71-e72 |
Journal | European Urology |
Volume | 75 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Mar 2019 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results. / Boevé, Liselotte M. S.; Verhagen, Paul C. M. S.; Vis, André N.
In: European Urology, Vol. 75, No. 3, 01.03.2019, p. e71-e72.Research output: Contribution to journal › Letter › Academic › peer-review
TY - JOUR
T1 - Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410–8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial Until Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results
AU - Boevé, Liselotte M. S.
AU - Verhagen, Paul C. M. S.
AU - Vis, André N.
PY - 2019/3/1
Y1 - 2019/3/1
UR - http://www.scopus.com/inward/record.url?scp=85060699938&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2018.11.007
DO - 10.1016/j.eururo.2018.11.007
M3 - Letter
C2 - 30471883
VL - 75
SP - e71-e72
JO - European Urology
JF - European Urology
SN - 0302-2838
IS - 3
ER -